Designing Clinical Studies for Metabolic Health Devices: Endpoints Sponsors Should Consider
When developing a novel medical product, endpoint selection is arguably one of the most important decisions a sponsor will make. In the rapidly evolving sector of digital and hardware-based interventions, this choice becomes even more critical. Sponsors face a complex set of challenges: proving genuine clinical relevance, supporting a robust regulatory or claims strategy, selecting […]